Crinetics Pharmaceuticals (CRNX) Other financing activities (2018 - 2026)

Crinetics Pharmaceuticals' Other financing activities history runs 4 years deep, the most recent figure standing at $578000.0 for Q1 2026.

• In Q1 2026, Other financing activities changed N/A year-over-year to $578000.0; the TTM figure through Mar 2026 stood at -$15.4 million (down 27.53% YoY), while the FY2023 annual figure was $26000.0, changed N/A from the prior year.
• Other financing activities was $578000.0 for Q1 2026 at Crinetics Pharmaceuticals, up from -$15.9 million in the prior quarter.
• In the past five years, Other financing activities ranged from a high of $4.3 million in Q1 2024 to a low of -$15.9 million in Q4 2024.
• Historically, Other financing activities has averaged -$2.9 million across 3 years, with a median of $74500.0 in 2023.
• Biggest YoY gain for Other financing activities was 3617.72% in 2024; the steepest drop was 3617.72% in 2024.
• A 3-year view of Other financing activities shows it stood at -$429000.0 in 2023, then plunged by 3617.72% to -$15.9 million in 2024, then soared by 103.62% to $578000.0 in 2026.
• The last three Other financing activities figures came in at $578000.0 (Q1 2026), -$15.9 million (Q4 2024), and $4.3 million (Q1 2024), per Business Quant data.